Sipai Health Technology Past Earnings Performance
Past criteria checks 0/6
Sipai Health Technology has been growing earnings at an average annual rate of 9.4%, while the Consumer Retailing industry saw earnings growing at 31.5% annually. Revenues have been growing at an average rate of 17.6% per year.
Key information
9.4%
Earnings growth rate
25.0%
EPS growth rate
| Consumer Retailing Industry Growth | 28.3% |
| Revenue growth rate | 17.6% |
| Return on equity | -15.1% |
| Net Margin | -5.4% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Revenue & Expenses Breakdown
How Sipai Health Technology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 4,712 | -256 | 650 | 46 |
| 30 Sep 23 | 4,691 | -686 | 737 | 49 |
| 30 Jun 23 | 4,670 | -1,117 | 825 | 52 |
| 31 Mar 23 | 4,395 | -1,244 | 869 | 57 |
| 31 Dec 22 | 4,119 | -1,371 | 913 | 63 |
| 30 Sep 22 | 3,966 | -1,474 | 923 | 63 |
| 30 Jun 22 | 3,812 | -1,577 | 932 | 64 |
| 31 Mar 22 | 3,643 | -2,659 | 950 | 62 |
| 31 Dec 21 | 3,474 | -3,740 | 968 | 59 |
| 31 Dec 20 | 2,700 | -1,043 | 550 | 46 |
| 31 Dec 19 | 1,039 | -595 | 337 | 25 |
Quality Earnings: 314 is currently unprofitable.
Growing Profit Margin: 314 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 314 is unprofitable, but has reduced losses over the past 5 years at a rate of 9.4% per year.
Accelerating Growth: Unable to compare 314's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 314 is unprofitable, making it difficult to compare its past year earnings growth to the Consumer Retailing industry (3.1%).
Return on Equity
High ROE: 314 has a negative Return on Equity (-15.12%), as it is currently unprofitable.